Get started
Author

Christina Maria Rimpa

Observed names: C.M. Rimpa, Christina-Maria Rimpa, Maria-Christina Rimpa
ORCID: 0009-0006-1933-2752
Observed ORCID: 0009-0006-1933-2752
OpenAlex ID: A5081707718
Precision Immunotherapy to Improve Sepsis Outcomes
2025 · Evangelos J. Giamarellos-Bourboulis, Antigone Kotsaki, et al. · JAMA · 98
Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024 · Athanasios Tasis, Nikos E. Papaioannou, et al. · Cancer Research Communications · 11
PDF
Remdesivir: Effectiveness and Safety in Hospitalized Patients with COVID-19 (ReEs-COVID-19)—Analysis of Data from Daily Practice
2023 · Nikos Pantazis, Evmorfia Pechlivanidou, et al. · Microorganisms · 8
PDF
Characterization of the Molecular Signature of Human Monocytes in Aging and Myelodysplastic Neoplasms
2024 · Christina Maria Rimpa, Maria Grigoriou, et al. · European Journal of Immunology · 2
PDF
Data from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024 · Athanasios Tasis, Nikos E. Papaioannou, et al. · 1
Prognosis - Predictive Factors of Response to Treatment
2025 · George Vrachiolias, Eleftheria Lamprianidou, et al. · Leukemia Research
Plenary Session 08: Treatment High Risk
2025 · Despoina Dimitriou, Panagiotis Liakopoulos, et al. · Leukemia Research
Supplementary Data from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2025 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Data sheet 3 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2025 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Data sheet 2 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2025 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Data sheet 1 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2025 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Data sheet 1 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2025 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Data sheet 3 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2025 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Data sheet 2 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2025 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Supplementary Data from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2025 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Data sheet 3 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Figure 3 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Figure 7 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Data sheet 1 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Figure 2 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Figure 4 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Data sheet 2 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Figure 1 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Figure 6 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Figure 5 from Single-Cell Analysis of Bone Marrow CD8+ T Cells in Myeloid Neoplasms Reveals Pathways Associated with Disease Progression and Response to Treatment with Azacitidine
2024 · Athanasios Tasis, Nikos E. Papaioannou, et al.
Works count: 30
Citation count: 119
H-index: 3
I10-index: 2
Year
Topic
Type